In vitro efficacy of ARQ 092, an allosteric AKT inhibitor, on primary fibroblast cells derived from patients with PIK3CA-related overgrowth spectrum (PROS) - Ranieri, C; Di Tommaso, S; Loconte, D C (Neurogenetics, 2018)